- Home
- PKBK vs CDTX Comparison
PKBK vs CDTX Comparison
Compare PKBK & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- CDTX
- Stock Information
- Founded
- PKBK 1999
- CDTX 2012
- Country
- PKBK United States
- CDTX United States
- Employees
- PKBK N/A
- CDTX N/A
- Industry
- PKBK Major Banks
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PKBK Finance
- CDTX Health Care
- Exchange
- PKBK Nasdaq
- CDTX Nasdaq
- Market Cap
- PKBK 223.5M
- CDTX 259.0M
- IPO Year
- PKBK N/A
- CDTX 2015
- Fundamental
- Price
- PKBK $19.63
- CDTX $18.63
- Analyst Decision
- PKBK
- CDTX Strong Buy
- Analyst Count
- PKBK 0
- CDTX 8
- Target Price
- PKBK N/A
- CDTX $38.50
- AVG Volume (30 Days)
- PKBK 22.9K
- CDTX 92.3K
- Earning Date
- PKBK 04-17-2025
- CDTX 05-08-2025
- Dividend Yield
- PKBK 3.66%
- CDTX N/A
- EPS Growth
- PKBK 24.29
- CDTX N/A
- EPS
- PKBK 2.41
- CDTX N/A
- Revenue
- PKBK $64,206,999.00
- CDTX $302,000.00
- Revenue This Year
- PKBK N/A
- CDTX N/A
- Revenue Next Year
- PKBK N/A
- CDTX N/A
- P/E Ratio
- PKBK $8.17
- CDTX N/A
- Revenue Growth
- PKBK N/A
- CDTX N/A
- 52 Week Low
- PKBK $15.24
- CDTX $10.14
- 52 Week High
- PKBK $24.29
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- PKBK 63.01
- CDTX 39.70
- Support Level
- PKBK $18.97
- CDTX $19.97
- Resistance Level
- PKBK $19.94
- CDTX $22.80
- Average True Range (ATR)
- PKBK 0.49
- CDTX 1.47
- MACD
- PKBK 0.13
- CDTX -0.21
- Stochastic Oscillator
- PKBK 84.26
- CDTX 2.90
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.